Journal of Clinical Neurology and Neurosurgery

ISSN: 2684-6012

Open Access

Chuanhai Cao

Department of Chemistry, University of South Florida, USA

  • Short Communication   
    Coffee Consumption Provides Therapeutic Benefits against AD through Increasing Plasma GCSF Levels and Improving Cognitive Performance
    Author(s): Umer Nawaz Khan and Chuanhai Cao*

    Alzheimer's disease (AD) a progressive neurodegenerative disease that destroys memory and other important mental functions. More than 5 million Americans are living with AD. This number is expected to drastically increase as the baby boomer population transitions into the late-adulthood age group. Currently, the treatment for AD includes FDA drugs that focus on treating the symptoms. These types of drugs lose their efficacy as the disease progresses. Therefore, preventive measures are very critical in decreasing the incidence rate of AD. Many epidemiological studies have been conducted on the treatment of Alzheimer's that suggest enhanced coffee/caffeine intake during aging reduces the risk of AD. As one of most popular beverages in the World, many experimental studies have been done to test the effects of coffee consumption on AD. This paper will aim to re.. Read More»

    Abstract PDF

50+ Million Readerbase

Recommended Conferences

Journal Highlights

Google Scholar citation report
Citations: 1

Journal of Clinical Neurology and Neurosurgery received 1 citations as per Google Scholar report

Journal of Clinical Neurology and Neurosurgery peer review process verified at publons

Indexed In

arrow_upward arrow_upward